HIGHLIGHTS OF PRESCRIBING INFORMATION ...
4 Patients with congenital long QT syndrome, history of QT interval prolongation, family history of long QT syndrome or sudden cardiac death, and other conditions that predispose to QT interval prolongation and
Download HIGHLIGHTS OF PRESCRIBING INFORMATION ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Patient Information Single-Dose Prefilled Syringe
www.pi.amgen.comPatient Information Neulasta®(nu-las-tah) (pegfilgrastim) injection Single-Dose Prefilled Syringe What is Neulasta? Neulasta is a man-made form of granulocyte colony-stimulating factor (G-CSF).
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.pi.amgen.comPage 2 of 20 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Prevention of Cardiovascular Events In adults with established cardiovascular disease, REPATHA® is indicated to reduce the risk of myocardial infarction, stroke, and coronary revascularization.
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.comPage 3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Multiple Myeloma and Bone Metastasis from Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in
See full prescribing information for complete boxed warning.
www.pi.amgen.com5 • See Table 2 for the recommended dose by patient weight and schedule. Patients greater than or equal to 45 kg receive a fixed-dose and for patients less than 45 …
HIGHLIGHTS OF PRESCRIBING INFORMATION NEULASTA …
www.pi.amgen.com3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Patients with CancerReceiving Myelosuppressive Chemotherapy Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.pi.amgen.comTransplantation 14.4 Patients Undergoing Autologous Peripheral Blood Progenitor Cell Collection and Therapy 14.5 Patients with Severe Chronic Neutropenia 14.6 Patients Acutely Exposed to Myelosuppressive Doses of Radiation (Hematopoietic Syndrome of Acute Radiation Syndrome) 16 HOW SUPPLIED/STORAGE AND HANDLING
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.com• as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy. (1, 14) -----DOSAGE AND ADMINISTRATION----- • Hydrate prior to and following Kyprolis as needed. (2.1)
HIGHLIGHTS OF PRESCRIBING INFORMATION PROLIA.
www.pi.amgen.comLatex Allergy: People sensitive to latex should not handle the gray needle cap on the single-dose prefilled syringe, which contains dry natural rubber (a derivative of latex). Prior to administration, Prolia may be removed from the refrigerator and brought to room temperature (up to 25°C/77°F) by standing in the original container.
Patient Information REPATHA (ri-PAth-a) (evolocumab ...
www.pi.amgen.com1 Patient Information REPATHA® (ri-PAth-a) (evolocumab) injection, for subcutaneous use What is REPATHA? REPATHA is an injectable prescription medicine used:
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.com• To decrease these risks, as well as the risk of serious cardiovascular and thromboembolic reactions, use the lowest dose needed to avoid RBC transfusions [see Dosage and Administration (2.3)]. • Use ESAs only for anemia from myelosuppressive chemotherapy [see Indications and …
Related documents
PRODUCT MONOGRAPH INCLUDING CONSUMER …
products.sanofi.caPRODUCT MONOGRAPH . INCLUDING CONSUMER INFORMATION . PrNOZINAN . Methotrimeprazine Hydrochloride Injection, USP. 25 mg/mL methotrimeprazine as …
PRODUCT MONOGRAPH INCLUDING PATIENT …
purdue.caFOQUEST™ (methylphenidate hydrochloride CR capsules) Page 1 of 37 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST™ methylphenidate hydrochloride
Participating Hospital Certification Form
amtrial.comPlease see accompanying FULL PRESCRIBING INFORMATION, including BOXED WARNING. Page 6 of 6 IMPORTANT SAFETY INFORMATION for ABILIFY MAINTENA® (aripiprazole) (Continued) Orthostatic Hypotension: ABILIFY MAINTENA may cause orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions …
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
Brief Overview of Common Psychotropic Medications
secure.ce-credit.comBrief Overview of Common Psychotropic Medications: A Practical Guide from a Clinical Viewpoint Paula Bank, M.D., Ph.D. Dept. of Psychiatry University of Michigan
patients for whom alternative treatment options (e.g., non ...
www.accessdata.fda.govHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CONZIP® safely and effectively. See full precribing information for s
HIGHLIGHTS OF PRESCRIBING INFORMATION hypotension, …
www.astellas.usFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE LEXISCAN® (regadenoson) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.